Browse Category

Investing News 24 October 2025

Palantir (PLTR) Stock Soars on AI Hype – Is It a Bubble or the Next Tech Giant?

Palantir (PLTR) Stock Skyrockets on AI Boom – What Investors Need to Know

Market Action & Stock Performance Palantir Technologies (NYSE: PLTR) has been among the most-watched tech stocks in late October 2025, as investors chase AI-related growth stories. Over the past week, PLTR shares jumped sharply on the back of a broad

24 October 2025

Broadcom’s AI Windfall: Inside AVGO’s Trillion-Dollar Surge, $10B Chip Deal & 2025 Outlook

Broadcom (AVGO) Stock Skyrockets on $10B OpenAI AI Chip Deal — Are $450 Targets Next?

Broadcom’s stock has soared in recent days as the chipmaker emerges as a central player in the booming AI industry. On Friday, Oct. 24, the shares were trading in the mid-$350s – about double their level a year earlier –

24 October 2025

Artificial Intelligence · Investing · Market News · NASDAQ:AVGO · Stocks · Technology

Apple Stock Hits New Heights: iPhone 17 Supercycle, Analyst Split, and 2025 Outlook Revealed

Apple (AAPL) Stock Rockets to Record High on iPhone 17 Hype — What’s Next?

Near-Term Move: Riding the Rally Apple shares have been volatile but are trading very near record levels. On Oct. 20, investors bid the stock up sharply – by the close it was ~$262 (intraday as high as ~$264) ts2.tech. Since then

24 October 2025

Apple · Investing · iPhone · NASDAQ:AAPL · Stock Market · Technology

Grindr Stock Skyrockets on Buyout Buzz – What Investors Need to Know

Buyout Buzz Sends GRND Soaring Grindr’s stock price skyrocketed after news of a potential insider buyout broke. On Friday, Oct. 24, GRND opened at $14.50 and surged as high as $16.22 intraday, an approximately 25% jump from the prior day’s

24 October 2025

Financial News · Investing · LGBTQ+ Business · Mergers & Acquisitions · NYSE:GRND · Stock Market

Theriva Biologics (TOVX) Stock Soars 92% on Oncolytic Virus Trial News – Can the Rally Last?

Theriva Biologics (TOVX) Stock Surges on Cancer Trial Breakthrough – What’s Next?

Theriva’s Stock Swing: In mid-October, Theriva’s Nasdaq-traded shares spiked on news of clinical success. On Oct. 15 the stock jumped from roughly $0.44 to $0.84 intraday ts2.tech, an increase of about 92%. This surge coincided with reports that VCN-01 had

24 October 2025

Biotech · Cancer Research · Clinical Trials · Investing · NASDAQ:TOVX · Stock Market

Comfort Systems (FIX) Stock Skyrockets 17% After Stellar Q3 — What’s Driving the Rally?

Shares of Comfort Systems USA (NYSE: FIX) exploded on Oct. 24 after the company reported blowout third-quarter results. FIX jumped to about $970 in early trading — up ~17% from the prior close benzinga.com — as investors cheered earnings and backlog far

24 October 2025

Earnings Reports · Financial News · Investing · Market Analysis · NYSE:FIX · Stock Market

MultiSensor AI Stock’s Wild Ride: +42% Rally on Major Deal, –50% Crash After $14M Funding

MultiSensor AI (NASDAQ: MSAI) – Shares skyrocketed in late October 2025 and then plunged, reflecting news-driven swings. On Oct. 23 the stock jumped (roughly +42–100%) after the company announced a major U.S. deployment deal ts2.tech. By Oct. 24 it fell

24 October 2025

Artificial Intelligence · Financial News · Investing · NASDAQ:MSAI · Stock Market · Technology

Adverum (ADVM) Stock Skyrockets on News of Lilly’s $12.47/Share Gene Therapy Deal

Sources: Official press releases and filings investors.adverum.com investors.adverum.com, Reuters, Investing.com, Fierce Biotech fiercebiotech.com, and analyst reports marketbeat.com marketbeat.com. All data as of market close Oct. 23, 2025 and news through Oct. 24, 2025.

24 October 2025

Biotech News · Gene Therapy · Investing · Mergers and Acquisitions · NASDAQ:ADVM · NYSE:LLY · Stock Market

Neuphoria Stock Crashes After Social Anxiety Trial Failure — What’s Next?

Key Facts: – Neuphoria (Nasdaq: NEUP) shares plunged ~67% in after-hours trading on Oct 20 when its lead drug BNC210 failed a Phase 3 SAD trial investing.com. The AFFIRM-1 trial missed both primary and secondary endpoints, and the company immediately

24 October 2025

Biotech · Clinical Trials · Investing · Mental Health · NASDAQ:NEUP · Stock Market

AMD Stock Skyrockets on AI Mega-Deals – Is $300 Next?

In summary, AMD’s recent AI-driven surge has been fueled by heavyweight partnerships and robust demand, earning plaudits from executives and analysts alike. But the stock now sits at lofty valuations. Investors will be watching closely whether AMD can translate its

24 October 2025

Artificial Intelligence · Financial News · Investing · NASDAQ:AMD · Stock Market · Technology

Plug Power (PLUG) Stock Skyrockets 170% on Hydrogen Hype – Can It Last?

Stock Performance and Volatility Plug Power’s share price has been on a roller-coaster. After languishing around $1.50 in late summer 2025, the stock surged to a new 52-week high near $4.58 in early October marketbeat.com ts2.tech. By Oct. 23 it

24 October 2025

Financial News · Hydrogen Economy · Investing · NASDAQ:PLUG · Renewable Energy · Stock Market

CrowdStrike (CRWD) Stock Soars on AI Cybersecurity Boom — Record Highs

Stock Price and Recent Rally CrowdStrike’s stock has climbed sharply in October. After trading near $484 in mid-October, the share price jumped into the $520s by Oct 23 investing.com. For example, CRWD rose 3.91% on Oct 20 and 4.37% on

24 October 2025

AI Technology · Cybersecurity · Financial News · Investing · NASDAQ:CRWD · Stock Market

Previous 1 … 152 153 154 155 156 … 196 Next

Go toTop